ERAS in Choledochal Cyst & Biliary Atresia
NCT07709702 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-07-16
Summary
This study aims to compare two feeding approaches after surgery for biliary atresia and choledochal cyst in children.
Traditionally, children are kept without oral feeding for more than 48 hours after these operations until bowel activity returns. However, newer Enhanced Recovery After Surgery (ERAS) programs suggest that starting feeding earlier may help children recover faster.
In this study, children undergoing surgery for biliary atresia or choledochal cyst will be randomly assigned to one of two groups. One group will start oral liquids within 24 hours after surgery and gradually progress to normal feeding as tolerated (early feeding group). The other group will receive conventional care, where feeding is started after more than 48 hours once bowel activity has returned.
Researchers will compare both groups for postoperative complications such as wound infection and anastomotic leakage, as well as the duration of hospital stay. Additional observations will include vomiting, abdominal distension, need for reinsertion of a nasogastric tube, requirement for repeat surgery, and time taken to resume normal feeding.
Participation in the study will not affect the standard surgical treatment provided. All children will receive routine perioperative care and will be monitored closely throughout their hospital stay and follow-up visits. The findings of this study may help determine whether early oral feeding is a safe and effective strategy to improve recovery and reduce hospitalization after pediatric hepatobiliary surgery.
Conditions
- Choledochal Cyst Resection
- Biliary Atresia, Kasai Portoenterostomy Status
Interventions
- OTHER
-
Enhanced Recovery After Surgery
In ERAS feeding protocol or early oral feeding protocol, patients will be allowed oral liquids within 24 hours of surgery irrespective of confirmation of bowel functions.
- OTHER
-
Post-operative care
In conventional feeding protocol, feeds will be resumed after surgery on confirmation of bowel functions with auscultation for bowel sounds or passage of stool or flatus, usually after 48 hours
Sponsors & Collaborators
-
University of Child Health Sciences and Children's Hospital, Lahore
collaborator OTHER -
Muhammad Zubair Shoukat
lead OTHER
Principal Investigators
-
Sundas Zahra, MBBS · University of Child Health sciences & The Children's Hospital, Lahore
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Month
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-27
- Primary Completion
- 2026-07-31
- Completion
- 2026-08-31
Countries
- Pakistan
Study Locations
More Related Trials
-
RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.
NCT00539565 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia
NCT02298218 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai
NCT04524390 ·Status: COMPLETED ·Phase: PHASE2
-
Grape Seed Powder and Vitamin C Supplementation for Liver Disease (Acquired Hepatic Jaundice)
NCT07575789 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts
NCT02048319 ·Status: COMPLETED ·Phase: PHASE3
-
Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.
NCT02192177 ·Status: UNKNOWN
-
Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
NCT06121375 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy
NCT00294684 ·Status: COMPLETED ·Phase: NA
-
Primary Prophylaxis for Variceal Bleed in Biliary Atresia
NCT04494763 ·Status: UNKNOWN ·Phase: NA
-
Fibrates in Pediatric Cholestasis
NCT03586674 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
NCT04823780 ·Status: COMPLETED
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
NCT05925309 ·Status: RECRUITING ·Phase: NA
-
To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
NCT03161106 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.
NCT04013074 ·Status: UNKNOWN ·Phase: NA
-
Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.
NCT05690750 ·Status: UNKNOWN
-
Prealbumin and IGF-1 Levels in Pediatric Chronic Cholestasis With Severe Malnutrition After Nutrition Therapy
NCT07569003 ·Status: RECRUITING ·Phase: NA
-
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
NCT04542473 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
NCT00004410 ·Status: COMPLETED ·Phase: NA
-
Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.
NCT06676813 ·Status: RECRUITING ·Phase: NA
-
Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy
NCT07634237 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
NCT04221672 ·Status: UNKNOWN ·Phase: PHASE3
-
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis
NCT03069339 ·Status: UNKNOWN ·Phase: NA
-
Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
NCT07002827 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.
NCT04066179 ·Status: UNKNOWN ·Phase: NA